Evidence map›Paper›PMID 41313496›Full record

ArticleMolecular biology reports2025

The role of miR-34a gene expression in Zearalenone-mediated toxicity in vitro: the protective effect of Lactobacillus acidophilus.

Sodabe Khodabandehlou, Fatemeh Nouri, Mohammad Reza Arabestani, Ali Heshmati, Akram Ranjbar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sodabe KhodabandehlouDepartment of Pharmacology Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Fatemeh NouriPharmaceutical Sciences Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohammad Reza ArabestaniDepartment of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Ali HeshmatiDepartment of Nutrition and Food Hygiene, School of Medicine, Nutrition Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Akram RanjbarDepartment of Pharmacology Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran. a.ranjbar@umsha.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZearalenone (ZEN), an important mycotoxin produced by Fusarium species, poses significant health threat due to estrogenic and cytotoxic effects. This study aimed to investigate protective effects of Lactobacillus acidophilus (L. acidophilus) against on ZEN-induced cytotoxicity and its influence on miRNA-34a expression in HepG2 cell line.

methodsHepG2 cells were seeded in 96-well plates and incubated at 37 °C for 24 h; then survival rate of HepG2 cells treated with different concentrations of 100-200µM zearalenone and probiotics was calculated using MTT method and IC50 value was calculated using Prism version 9 software. Lactate dehydrogenase activity, a marker of cellular damage, was measured. Additionally, the expression of miRNA-34a, a microRNA potentially involved in ZEN-mediated cytotoxicity, was quantified using real-time PCR with specific primers.

resultsThe expression of miRNA-34a gene in HepG2 cells exposed to ZEN treated with L. acidophilus.

conclusionThe results of the present study showed probiotics moderate the toxic effects of this mycotoxin.

Indexed as

Lactobacillus acidophilusMicroRNAsZearalenoneCell SurvivalGene Expression RegulationHep G2 CellsHumansMycotoxinsProbioticsMicroRNAsMIRN34 microRNA, humanMycotoxinsZearalenoneIn vitroLactobacillus acidophilusMiRNA-34aZearalenone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.